Linda Stein Gold mentions in a video posted on Skin and Allergy News, referring to Galderma’s Ivermectin Cream ;

• Phase 3 Clinical Trials have completed, and
• FDA Approval is expected later this year (2014).

This is great new for those who 1) want to try an approved treatment for demodex mites and 2) may not be happy with their usage of Metrogel.

The clinical trial data suggests that after 14 days of treatment, the treatment was starting to work and after 4 weeks, 30% of patients were reported to be clear of the papules and pustules of rosacea.

Ivermectin is being described as safe and effective. Indeed this interview suggests that the Ivermectin cream may have less side effects that the vehicle that carries the active molecule!

Ivermectin is said to have 2 methods of action – anti inflammatory and its parasitic actions against demodex.

VIDEO: Ivermectin shows promise for treating papulopustular rosacea

Mar 23, 2014

Video recorded as part of the AAD Annual Meeting in Denver, CO.

Dr. Stein Gold was a clinical investigator for the trial and is a consultant for Galderma.

Related Articles

• Ivermectin Cream works really well, but Nobody Knows Why!
• More Proof that CD5024 is Ivermectin
• Topical Ivermectin Patent for Rosacea
• Topical Ivermectin + Metrogel from Galderma
• CD5024 Cream in Phase 3 Trials (Ivermectin 1%)
• Sklice, Topical Ivermectin 0.5% for Head Lice on Scalp and Hair